Effects of Repeated Intrathecal Triamcinolone-Acetonide Application on Cerebrospinal Fluid Biomarkers of Axonal Damage and Glial Activity in Multiple Sclerosis Patients
Paulus Rommer(Medical University of Vienna), Uwe K. Zettl(University of Rostock), R. Benecke(Children's Hospital of Philadelphia), F Kamin(University of Rostock), Hayrettin Tumani, Axel Petzold(University College London), Alexander Winkelmann(University of Rostock), Mazen Abu‐Mugheisib(University of Rostock), F. Hoffmann(Martha-Maria Hospital), Wolfgang Köehler(Fachkrankenhaus Hubertusburg)
Cited by 15
Related Papers
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
|Journal of Neuroinflammation|2016|896
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
|Nature Reviews Neurology|2022|809
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
|The Lancet Neurology|2017|572
Myelin-oligodendrocyte glycoprotein antibody-associated disease
|The Lancet Neurology|2021|518
Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses
|Annals of Neurology|2015|436